SONUS PHARMACEUTICALS, INC.Sonus Pharmaceuticals Inc • January 17th, 2008 • In vitro & in vivo diagnostic substances • Delaware
In consideration of your continued employment with SONUS Pharmaceuticals, Inc., a Delaware corporation (the “Company”), you and the Company entered into a Change in Control Agreement dated October 10TH, 2003 (the “Prior Agreement’”). For good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, you and the Company desire to amend and restate the Prior Agreement as set forth herein. This new Severance/Change in Control Agreement (the “Agreement”) amends and restates the Prior Agreement and sets forth the compensation and benefits you will be entitled to receive in the event your employment terminates under any of the circumstances outlined in Section 1 below. This Agreement takes effect on the date set forth above.
